Rectal Cancer
Malignancy
APP
DEI
Matthew Kalady, MD
Professor, Division Director,
The Ohio State University Wexner Medical Center and James Cancer Center
Ohio State University
Columbus, Ohio, United States
All disclosed relationships have been reviewed and managed prior to the start of this activity. Any relevant relationships will be listed below. This individual has no relevant financial relationships.
Vassiliki Tsikitis, MD
All disclosed relationships have been reviewed and managed prior to the start of this activity. Any relevant relationships will be listed below. This individual has no financial relationships to disclose
CME .75 hours
There has been an alarming increase in the incidence of colorectal cancer in patients less than 50 years old over the last few decades in the United States. The majority of these cases are in the rectum. The cause of this increase is likely multifactorial, and there are still significant knowledge gaps. In addition, the treatment paradigms for rectal cancer in younger patients present unique challenges as radiation and chemotherapy impact fertility. Furthermore, there is some debate about routinely using non-operative management in younger patients as the true long-term follow-up is still unknown.
This symposium will discuss the following: 1. The clinical evaluation of early onset rectal cancer, including indications and interpretation of genetic testing; 2. The impact of treatments on fertility and sexual health, and means to mitigate these; 3. The unique challenges and use of non-operative management in early onset rectal cancer patients.
Faculty: Karin Hardiman, MD, Ph.D (she/her/hers) – University of Alabama at Birmingham
Faculty: Pasithorn Amy Suwanabol, MD, MS (she/her/hers) – University of Michigan
Faculty: Julio Garcia Aguilar